Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: The exact cause of Poland Syndrome remains unknown, though it is widely believed to result from an interruption of blood supply (subclavian artery disruption) to the developing fetus during the first six weeks of gestation. While most cases occur sporadically without a clear genetic inheritance pattern, ongoing research continues to explore potential, albeit rare, genetic markers and environmental triggers associated with the condition. What is the primary theory behind the development of Poland Syndrome? The prevailing medical consensus for the etiology of Poland Syndrome is the "vascular disruption theory." During early embryonic development—specifically between the 4th and 6th week of gestation—the fetal blood supply to the developing chest wall and upper limb is interrupted.
12 people with Poland Syndrome have shared their first-person experience on this question at DiseaseMaps.
TL;DR: The exact cause of Poland Syndrome remains unknown, though it is widely believed to result from an interruption of blood supply (subclavian artery disruption) to the developing fetus during the first six weeks of gestation. While most cases occur sporadically without a clear genetic inheritance pattern, ongoing research continues to explore potential, albeit rare, genetic markers and environmental triggers associated with the condition.
The prevailing medical consensus for the etiology of Poland Syndrome is the "vascular disruption theory." During early embryonic development—specifically between the 4th and 6th week of gestation—the fetal blood supply to the developing chest wall and upper limb is interrupted. This disruption, often involving the subclavian artery, prevents the proper growth of the pectoralis major muscle and can affect the development of the ribs, breast tissue, and hand bones. Because this is a localized event during a critical window of development, Poland Syndrome is typically present at birth (congenital) but is not considered a systemic or progressive disease.
In the vast majority of cases, Poland Syndrome is sporadic, meaning it occurs in individuals with no family history of the condition. While researchers have extensively studied the genetics of the syndrome, there is no single "Poland Syndrome gene" that has been identified. For the 727 members of our DiseaseMaps community and the broader patient population, it is important to understand the distinction between genetic and hereditary:
Because Poland Syndrome is characterized by a disruption in fetal development, researchers have investigated various environmental factors. However, no specific maternal behavior, medication, or exposure has been definitively linked to the condition. It is essential for parents to know that there is currently no evidence that Poland Syndrome is caused by anything a parent did or did not do during pregnancy. It is largely viewed as a chance event in the complex process of fetal blood vessel formation.
Modern research into Poland Syndrome is shifting toward understanding the molecular signaling pathways that govern limb and muscle development. Scientists are examining how disruptions in the subclavian artery interact with the signaling proteins that tell the body where to grow muscles and bones. By analyzing the 727 personal experiences shared by our community, researchers hope to identify potential patterns that could lead to a better understanding of why Poland Syndrome affects the right side of the body more frequently than the left, and why it presents with such wide variability in severity.
Medical Disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.